2020
DOI: 10.1016/j.bmcl.2019.126781
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization and bioactivities of a new covalent copper(II) compound derived from {P2Mo5O23}6− and thiosemicarbazones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Quite recently, a Cu(II) hybrid system containing a polyoxometalate moiety and a 2-acetylpyrazine-TSC NN S chelator was proven to exhibit antibacterial activity against Escherichia coli and Staphilococcus aureus and a better cytotoxicity against human hepatic cancer cells (SMMC-7721) than Mitoxantone, the current chemical anticancer drug, with an IC 50 value of about 1.6 µg/mL [84].…”
Section: Introductionmentioning
confidence: 99%
“…Quite recently, a Cu(II) hybrid system containing a polyoxometalate moiety and a 2-acetylpyrazine-TSC NN S chelator was proven to exhibit antibacterial activity against Escherichia coli and Staphilococcus aureus and a better cytotoxicity against human hepatic cancer cells (SMMC-7721) than Mitoxantone, the current chemical anticancer drug, with an IC 50 value of about 1.6 µg/mL [84].…”
Section: Introductionmentioning
confidence: 99%